Summary
The fall in exogenous insulin requirements occurring after onset of juvenile diabetes mellitus is known as the phase of remission. In a retrospective study the incidence of remission period, its length and factors influencing it were determined. Remission occurred in 20% of those children who received conventional preparations. There was no sex differece in incidence of remission. A shorter duration of ketonuria after onset of treatment increased the chance of remission. Remission did not occur in those children aged less than 5 years. The results suggest that current initial management using mono-component insulin increases the possibility of remission.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Galloway, J. A., Root, M. A. 1972. New forms of insulin. Diabetes 21, 637–648.
Andersen, O. O. 1975. The immunogenic properties of highly purified insulin preparations. The clinical importance of insulin-binding antibodies. Acta Endocrinologica 78, 723–735.
Craig, O. 1977. Childhood diabetes and its management. Butterworth and Co. (Publishers) Ltd.
Ludvigsson, J., Heding, L. G., Larsson, Y., Leander, E. 1977. C-peptide in juvenile diabetes beyond the postinitial remission period—relation to clinical manifestations at onset of diabetes, remission and diabetic control. Acta Paediatr. Scand. 66, 177–184.
Ludvigsson, J., Heding, L. G. 1978. Beta-cell function in children with diabetes. Diabetes 27 (suppl. I), 230–234.
West, K. M. 1982. Hyperglycaemia as a cause of long term complications. In: Complications of Diabetes. Eds. H. Keen, J. Jarrett. Edward Arnold (Publishers) Ltd., 13–19.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hensey, O.J., Smith, C.S. The remission period in juvenile diabetes mellitus. Ir J Med Sci 152, 187–190 (1983). https://doi.org/10.1007/BF02954715
Issue Date:
DOI: https://doi.org/10.1007/BF02954715